Amsterdam, Netherlands

Denis Philippe Cedric Fenistein

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 15.5

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Denis Philippe Cedric Fenistein

Introduction

Denis Philippe Cedric Fenistein is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of anti-infective compounds, particularly in the treatment of bacterial infections such as Tuberculosis. With a total of 2 patents to his name, his work is recognized for its potential impact on public health.

Latest Patents

Fenistein's latest patents focus on innovative small molecule compounds. The first patent relates to anti-infective compounds that are specifically designed for the treatment of bacterial infections, with a strong emphasis on Tuberculosis. The second patent also addresses anti-infective compounds, detailing the use of 4H-pyrido[1,2-a]pyrimidin-4-one compounds for similar therapeutic applications.

Career Highlights

Throughout his career, Fenistein has worked with prestigious organizations such as Institut Pasteur Korea and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the field of medical research.

Collaborations

Some of his notable coworkers include Zaesung No and Jaeseung Kim. Their collaborative efforts have contributed to the advancement of research in anti-infective treatments.

Conclusion

Denis Philippe Cedric Fenistein's work in the development of anti-infective compounds showcases his dedication to addressing critical health challenges. His patents reflect a commitment to innovation in the medical field, particularly in combating bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…